Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4

AIDS Research and Human Retroviruses

Volumn 24, Issue 2, 2008, Pages 173-180

  Serra, Caterina ^a   Biolchini, Adriana ^a   Mei, Alessandra ^a   Kotenko, Sergei ^b   Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERFERON; INTERLEUKIN 29; LAMBDA 3 INTERFERON; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ATTACHMENT; VIRUS REPLICATION;

ANTIGENS, CD4; CELL LINE; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION PROFILING; HIV CORE PROTEIN P24; HIV-1; HUMANS; INTERFERON TYPE I; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 39549094216     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0198     Document Type: Article

References (33)

1. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al.: IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003;4:69-77.
2. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al.: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003;4:63-68.
3. Bartlett NW, Buttigieg K, Kotenko SV, and Smith GL: Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 2005;86:1589-1596.
4. Robek MD, Boyd BS, and Chisari FV: Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005;79:3851-3854.
5. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, and Paludan SR: Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006;80:4501-4509.
6. Uze G and Monneron D: IL-28 and IL-29: Newcomers to the interferon family. Biochimie 2007;89:729-734.
7. Brand S, Zitzmann K, Dambacher J, Beigel F, Olszak T, Vlotides G, et al.: SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 2005;331:543-548.
8. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, et al.: IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005;289:G960-968.
9. Meager A, Visvalingam K, Dilger P, Bryan D, and Wadhwa M: Biological activity of interleukins-28 and -29: Comparison with type I interferons. Cytokine 2005;31:109-118.
10. Mennechet FJ and Uze G: Interferon lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006;107:4417-4423.
11. Coccia EM, Severa M, Giacomini D, Remoli ME, Julkunen I, Cella M, et al.: Viral infection and toll-like receptor agonists induce a differential expression of type I and ′ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004;34:796-805.
12. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, and Dianzani F: Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 1998;12:183-190.
13. Serra C, Mameli G, Biolchini A, Ziccheddu M, Arru G, and Dolei A: Characterization of an HIV type 1 strain with preferential replication in adherent cells. AIDS Res Hum Retroviruses 2002;18:641-647.
14. Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, et al.: Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERVW endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 2007;88:264-274.
15. Valasek MA and Repa JJ: The power of real-time PCR. Adv Physiol Educ 2005;29:151-159.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408.
17. Dolei A, Serra C, Arca MV, Tilocca F, Pietravalle M, Alemanno L, et al.: Mutual interactions between HIV-1 and cytokines in adherent cells during acute infection. Arch Virol 1994;134:157-168.
18. Biolchini A, Curreli S, Ziccheddu M, Serra C, and Dolei A: Opposite effects of IFN-gamma on CCR5 and CXCR4 expression and on entry of M- and T-tropic HIV in epithelial cells. AIDS 2000;14:613-615.
19. Khalili M, Bernstein D, Lentz E, Barylski C, and Hoffman-Terry M: Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: Partially blinded, randomized multicenter trial. Dig Dis Sci 2005;50:1148-1155.
20. Fischl MA, Richman DD, Saag M, Meng TC, Squires KE, Holden-Wiltse J, et al.: Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197. J Acquir Immune Defic Syndr Hum Retroviral 1997;16:247-253.
21. Papas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, et al.: Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 2004;189:2185-2191.
22. Dolei A, Fattorossi A, D'Amelio R, Aiuti F, and Dianzani F: Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III. J Interferon Res 1986;6:543-549.
23. Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, et al.: Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992;176:739-750.
24. Pedroza-Martins L, Boscardin WJ, Anisman-Posner DJ, Redsar BN, Bryson YJ, Yang OO, et al.: Interferon-gamma decreases replication of primary R5 HIV-1 isolates in thymocytes. AIDS 2006;20:939-942.
25. Fan SX, Turpin JA, Aronovitz JR, and Meltzer MS: Interferongamma protects primary monocytes against infection with human immunodeficiency virus type 1. J Leukoc Biol 1994;56:362-368.
26. Zitzmann K, Brand S, Baehs S, Goke B, Meinecke J, Spottl G, Meyer, et al.: Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006;344:1334-1341.
27. Jordan WJ, Eskdale J, Boniotto M, Rodial M, Kellner D, and Gallagher G: Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29). Genes Immun 2007;8:13-20.
28. Brandon LW, Wehrly K, Swanstrom R, Platt E, Kabat D, and Chesebro B: Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages. J Virol 2005;79:4828-4837.
29. Kozak SL, Platt EJ, Madani N, Ferro FE Jr, Peden K, and Kabat D: CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 1997;71:873-882.
30. Cameron PU, Handley AJ, Baylis DC, Solomon AE, Bernard N, Purcell DF, et al.: Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes. J Virol 2007;81:2297-2306.
31. Rosenberg ZF and Fauci AS: Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression. Immunol Today 1990;11:176-180.
32. Zhang M, Drenkow J, Lankford CS, Frucht DM, Rabin RL, Gingeras TR, et al.: HIV regulation of the IL-7R: A viral mechanism for enhancing HIV-1 replication in human macrophages in vitro. J Leukoc Biol 2006;79:1328-1338.
33. Herbeuval JP and Shearer GM: HIV-1 immunopathogenesis: How good interferon turns bad. Clin Immunol 2007;123:121-128.